Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a new podcast Sallie Lamb, Head of the Rehabilitation Research Group at NDORMS talks about SARAH, the Strengthening and Stretching for Rheumatoid Arthritis of the Hand Trial.

SARAH logo

The trial has been identified as one of the five most important randomised controlled trials in physiotherapy published in the last 5 years by PEDro (which stands for Physiotherapy Evidence Database).The trials were nominated by PEDro users and an independent panel of international trialists to celebrate PEDro's 20th birthday. Listen to Sallie's podcast here

Entitled 'Exercises to Improve function of the Rheumatoid Hand' (SARAH), the trial appeared in the Lancet in January 2015.

PEDro is a free database of over 45,000 randomised trials, systematic reviews and clinical practice guidelines in physiotherapy. It is produced by the Institute for Musculoskeletal Health, School of Public Health at the University of Sydney and is hosted by Neuroscience Research Australia and can be found at: https://www.pedro.org.au/

Similar stories

Emergency departments to use the FORCE pathway for wrist fractures in children

New research from the University of Oxford has shown that doctors can simplify treatment for the most common fracture in children, reducing NHS costs.

Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases

A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.